Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C046782 |
14,15-epoxy-5,8,11-eicosatrienoic acid |
14,15-epoxy-5,8,11-eicosatrienoic acid results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 16286479
|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein | affects cotreatment|decreases activity|decreases phosphorylation | 16611854
|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased expression of TGFB1 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16611854
|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of KLF6 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16611854
|
C120227 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [EDN1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C120227 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C120227 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C439584 |
2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol |
2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 16954435
|
C439584 |
2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol |
temsirolimus promotes the reaction [2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol results in decreased phosphorylation of RPS6KB1 protein] | decreases phosphorylation|increases reaction | 16954435
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 14640974
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 15919668
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
[Sirolimus co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of RPS6KB1 protein | affects cotreatment|decreases phosphorylation | 18622747
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
U 0126 promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]] | decreases reaction|increases activity|increases phosphorylation|increases reaction | 15919668
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 16179367
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EDN1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 14769825
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein | decreases activity|decreases phosphorylation | 10993886
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of RPS6KB1 mRNA | decreases expression | 18648102
|
C103303 |
alitretinoin |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein | affects cotreatment|decreases activity|decreases phosphorylation | 16611854
|
C103303 |
alitretinoin |
RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased expression of TGFB1 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16611854
|
C103303 |
alitretinoin |
RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of KLF6 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16611854
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone inhibits the reaction [FSHB protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 17510244
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RPS6KB1 mRNA | affects expression | 16483693
|
D047310 |
Apigenin |
Apigenin results in decreased expression of RPS6KB1 protein | decreases expression | 15947208
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased activity of RPS6KB1 protein | decreases activity | 14633726
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 18048359
|
C015001 |
arsenite |
arsenite results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 17038550
|
D001241 |
Aspirin |
Aspirin results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein | decreases activity|decreases phosphorylation | 10993886
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12720544
|
C032036 |
bromobenzene |
bromobenzene results in increased expression of RPS6KB1 mRNA | increases expression | 15056800
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Serotonin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 18621911
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 15255942
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [PDGFB protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 15919668
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 15705590
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 14769825
|
D002118 |
Calcium |
Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein] | affects reaction|increases activity|increases phosphorylation | 12935885
|
D002217 |
Carbachol |
1-Butanol inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 15255942
|
D002217 |
Carbachol |
Carbachol results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 15255942
|
D003474 |
Curcumin |
Curcumin results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 18790744
|
D003609 |
Dactinomycin |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 14640974
|
D003609 |
Dactinomycin |
Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 14640974
|
D003609 |
Dactinomycin |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974
|
D003609 |
Dactinomycin |
PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974
|
C107676 |
deguelin |
deguelin metabolite results in decreased expression of RPS6KB1 protein | decreases expression | 19139008
|
C107676 |
deguelin |
deguelin results in decreased expression of RPS6KB1 protein | decreases expression | 19139008
|
C011612 |
diethyl sulfate |
diethyl sulfate inhibits the reaction [EGF protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12960407
|
C011612 |
diethyl sulfate |
diethyl sulfate inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 12960407
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 12971962
|
D004317 |
Doxorubicin |
NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of RPS6KB1 protein] | affects phosphorylation|affects reaction | 15833803
|
D004958 |
Estradiol |
Estradiol results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 16033851
|
D004958 |
Estradiol |
everolimus inhibits the reaction [Estradiol results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 16033851
|
D000431 |
Ethanol |
Ethanol results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 18377926
|
D000431 |
Ethanol |
Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 12935885
|
C107135 |
everolimus |
everolimus inhibits the reaction [Estradiol results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 16033851
|
C063007 |
exoenzyme C3, Clostridium botulinum |
exoenzyme C3, Clostridium botulinum inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 14769825
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of RPS6KB1 mRNA | increases expression | 18035473
|
D005978 |
Glutathione |
Glutathione deficiency results in increased expression of RPS6KB1 mRNA | increases expression | 15345336
|
D006632 |
Histamine |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D006632 |
Histamine |
Histamine results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 11959800
|
D006632 |
Histamine |
PD 98059 inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D006632 |
Histamine |
Pertussis Toxin inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D006632 |
Histamine |
Pyrilamine inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D006632 |
Histamine |
Sirolimus inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D006632 |
Histamine |
wortmannin inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 19451193
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of RPS6KB1 protein | increases expression | 18603805
|
D006861 |
Hydrogen Peroxide |
1-Butanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 15705590
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 15705590
|
D012701 |
Serotonin |
1-Butanol inhibits the reaction [Serotonin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 18621911
|
D012701 |
Serotonin |
PLD1 protein affects the reaction [Serotonin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | affects reaction|increases activity|increases phosphorylation | 18621911
|
D012701 |
Serotonin |
Serotonin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 18621911
|
C477872 |
IC 87114 |
IC 87114 results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 16179367
|
C097613 |
imatinib |
imatinib results in decreased expression of RPS6KB1 mRNA | decreases expression | 19208803
|
C097613 |
imatinib |
imatinib results in decreased expression of RPS6KB1 protein | decreases expression | 19208803
|
D007213 |
Indomethacin |
Indomethacin results in increased expression of RPS6KB1 mRNA | increases expression | 18299717
|
C032881 |
lysophosphatidic acid |
lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 17919812
|
C032881 |
lysophosphatidic acid |
resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 17919812
|
C032881 |
lysophosphatidic acid |
1-Butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 14769825
|
C032881 |
lysophosphatidic acid |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 14769825
|
C032881 |
lysophosphatidic acid |
exoenzyme C3, Clostridium botulinum inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 14769825
|
C032881 |
lysophosphatidic acid |
lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 14769825
|
D008727 |
Methotrexate |
Methotrexate results in increased expression of RPS6KB1 mRNA | increases expression | 15120968
|
D009355 |
Neomycin |
Neomycin affects the phosphorylation of RPS6KB1 protein | affects phosphorylation | 16537399
|
C404397 |
NSC 680410 |
NSC 680410 results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 14647418
|
C115711 |
PD 173074 |
[PKI 166 co-treated with PD 173074] results in decreased activity of RPS6KB1 protein | affects cotreatment|decreases activity | 15377668
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 17976640
|
D010656 |
Phenylephrine |
wortmannin inhibits the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 17976640
|
D010656 |
Phenylephrine |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D010656 |
Phenylephrine |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D010656 |
Phenylephrine |
bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12720544
|
D010656 |
Phenylephrine |
Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein] | affects reaction|increases activity|increases phosphorylation | 12935885
|
D010656 |
Phenylephrine |
DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 15757502
|
D010656 |
Phenylephrine |
Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 12935885
|
D010656 |
Phenylephrine |
[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein | increases activity|increases phosphorylation | 12935885
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 18562309
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 15795328 15757502
|
D010656 |
Phenylephrine |
Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12720544
|
D010656 |
Phenylephrine |
resveratrol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 18562309
|
D010656 |
Phenylephrine |
rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12720544
|
D010656 |
Phenylephrine |
SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein] | increases phosphorylation|increases reaction | 15795328
|
D010656 |
Phenylephrine |
Sirolimus inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D010656 |
Phenylephrine |
U 0126 inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D010712 |
Phosphatidic Acids |
[Phosphatidic Acids results in increased phosphorylation of MTOR protein] which results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 18621911
|
D010712 |
Phosphatidic Acids |
Phosphatidic Acids results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 15255942
|
C410026 |
PKI 166 |
[PKI 166 co-treated with PD 173074] results in decreased activity of RPS6KB1 protein | affects cotreatment|decreases activity | 15377668
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12720544
|
D011433 |
Propranolol |
Propranolol results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 16537399
|
D011433 |
Propranolol |
Sirolimus inhibits the reaction [Propranolol results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 16537399
|
D011738 |
Pyrilamine |
Pyrilamine inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 17919812
|
C059514 |
resveratrol |
resveratrol results in decreased expression of RPS6KB1 protein | decreases expression | 17534123
|
C059514 |
resveratrol |
resveratrol results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 16979140
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 18562309
|
C059514 |
resveratrol |
resveratrol results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 18562309
|
C085746 |
rottlerin |
rottlerin affects the phosphorylation of RPS6KB1 protein | affects phosphorylation | 17976640
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 17976640
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12720544
|
C085746 |
rottlerin |
rottlerin results in decreased activity of RPS6KB1 protein | decreases activity | 12720544
|
C093642 |
SB 203580 |
SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | increases activity|increases phosphorylation|increases reaction | 10993886
|
C093642 |
SB 203580 |
Sodium Salicylate inhibits the reaction [SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]] | decreases reaction|increases activity|increases phosphorylation|increases reaction | 10993886
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [EGF protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12960407
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 12960407
|
D020123 |
Sirolimus |
[Sirolimus co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of RPS6KB1 protein | affects cotreatment|decreases phosphorylation | 18622747
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 15919668
|
D020123 |
Sirolimus |
[Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases activity|decreases reaction|increases activity|increases phosphorylation | 15919668
|
D020123 |
Sirolimus |
Sirolimus results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein | decreases activity|decreases phosphorylation | 17616671 15914125
|
D020123 |
Sirolimus |
Sirolimus results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 15782132
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [Propranolol results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 16537399
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [TSC1 gene mutant form results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 18495876
|
D020123 |
Sirolimus |
Sirolimus results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 16537399
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [EDN1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D020123 |
Sirolimus |
Sirolimus results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 16391472
|
D020123 |
Sirolimus |
Sirolimus results in decreased activity of RPS6KB1 protein | decreases activity | 9836529
|
D020123 |
Sirolimus |
Sirolimus results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein | decreases activity|decreases phosphorylation | 10993886
|
D012980 |
Sodium Salicylate |
Sodium Salicylate inhibits the reaction [SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]] | decreases reaction|increases activity|increases phosphorylation|increases reaction | 10993886
|
D012980 |
Sodium Salicylate |
Sodium Salicylate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 10993886
|
D012980 |
Sodium Salicylate |
Sodium Salicylate promotes the reaction [[EGF protein co-treated with IGF1 protein] results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | affects cotreatment|increases activity|increases phosphorylation|increases reaction | 10993886
|
D012980 |
Sodium Salicylate |
Sodium Salicylate results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein | decreases activity|decreases phosphorylation | 10993886
|
C116890 |
SU 5416 |
SU 5416 results in decreased activity of RPS6KB1 protein | decreases activity | 15474452
|
D013629 |
Tamoxifen |
[Tamoxifen results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6KB1 protein | decreases activity|decreases phosphorylation | 19931998
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 19931998
|
D013629 |
Tamoxifen |
[Tamoxifen results in increased activity of AKT1 protein] which results in increased activity of RPS6KB1 protein | increases activity | 20372086
|
C401859 |
temsirolimus |
temsirolimus promotes the reaction [2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol results in decreased phosphorylation of RPS6KB1 protein] | decreases phosphorylation|increases reaction | 16954435
|
C401859 |
temsirolimus |
temsirolimus results in decreased phosphorylation of RPS6KB1 protein | decreases phosphorylation | 16033649 16954435
|
D013739 |
Testosterone |
[Testosterone results in increased activity of RAF1 protein] which results in increased activity of RPS6KB1 protein | increases activity | 20372086
|
D013755 |
Tetradecanoylphorbol Acetate |
RAF1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KB1 protein] | affects reaction|increases phosphorylation | 17976640
|
D013755 |
Tetradecanoylphorbol Acetate |
rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 17976640
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 17976640
|
D013755 |
Tetradecanoylphorbol Acetate |
SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | increases activity|increases phosphorylation|increases reaction | 10993886
|
D013755 |
Tetradecanoylphorbol Acetate |
Sodium Salicylate inhibits the reaction [SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]] | decreases reaction|increases activity|increases phosphorylation|increases reaction | 10993886
|
D013755 |
Tetradecanoylphorbol Acetate |
Sodium Salicylate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 10993886
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 10993886
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of RPS6KB1 mRNA | increases expression | 17127020
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity|increases phosphorylation | 15919668
|
C113580 |
U 0126 |
U 0126 promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]] | decreases reaction|increases activity|increases phosphorylation|increases reaction | 15919668
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [EDN1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D014639 |
Vanadium |
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | affects reaction|increases activity|increases phosphorylation | 14971662
|
D014639 |
Vanadium |
Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein | increases activity|increases phosphorylation | 14971662
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Histamine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 11959800
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 12960407
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein] | decreases reaction|increases phosphorylation | 17976640
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.89 | 14745880 |
MESH:D015746 |
Abdominal Pain |
|
SU 5416 |
6.55 | 12673719 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
6.88 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
6.88 | 12039119 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
4.68 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
5.56 | 18322153 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.35 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.35 | 11192467 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
4.85 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.28 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
11.27 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
11.27 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
11.27 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
11.27 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
11.27 | 16537180 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
12.70 | 3712494 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
12.70 | 19555203 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
12.70 | 11497255 |
MESH:D000236 |
Adenoma |
|
resveratrol |
12.70 | 15688382 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.93 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.66 | 15451040 15451039 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.43 | 17887948 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.72 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
5.61 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
5.61 | 17627676 15579461 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
5.61 | 16162502 16183991 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.19 | 15513904 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.20 | 7506515 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.49 | 11141031 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.24 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
4.25 | 10388637 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.56 | 17460149 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.51 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.08 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
6.42 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
6.42 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
6.42 | 17286800 |
MESH:D001249 |
Asthma |
|
Histamine |
3.67 | 16387687 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.16 | 20485159 12372130 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
4.99 | 7820390 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
5.54 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.54 | 16873680 17967414 |
MESH:D001284 |
Atrophy |
marker/mechanism |
|
| 16391472 |
MESH:D001321 |
Autistic Disorder |
|
Glutathione |
2.63 | 19056591 19267885 18929414 16917939 |
MESH:D001321 |
Autistic Disorder |
|
Propranolol |
2.63 | 18766980 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
2.63 | 18405062 18361446 8570775 19221690 18062943 15132762 17157402 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
2.63 | 21115397 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
3.87 | 19761891 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.36 | 10684365 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.36 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.10 | 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
10.13 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
10.13 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
4.73 | 15867366 |
MESH:D001919 |
Bradycardia |
|
Carbachol |
19.96 | 12411408 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
19.96 | 15306635 |
MESH:D001919 |
Bradycardia |
|
Propranolol |
19.96 | 6740701 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
19.96 | 8112388 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.37 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
13.41 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
13.41 | 12524144 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
13.41 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
11.56 | 15481559 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
11.56 | 17596214 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
11.56 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol |
14.11 | 16954435 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
14.11 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Apigenin |
14.11 | 17132221 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
14.11 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
14.11 | 19250217 16243823 18593918 18462866 |
MESH:D001943 |
Breast Neoplasms |
|
deguelin |
14.11 | 18593368 17035597 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
14.11 | 15692762 15668708 15634643 19526202 16595493 17983394 15993339 17369602 15567936 16096432 16935488 15939500 17426702 11325840 16826403 18628466 16264153 16115903 18695136 15136595 15994142 18234424 18382427 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
14.11 | 12948864 19861407 17289903 17261762 18497071 16675129 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
14.11 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
14.11 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
14.11 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
14.11 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
14.11 | 19011961 19103187 19487384 11161223 19289846 19115204 16818667 19059307 20390343 19155303 18997820 20544844 15565566 18351453 18821012 19142967 21152245 16202921 17893378 20135344 17440819 18855134 18815881 16273361 19244106 18629630 15668708 19066611 19200415 18425577 19084267 17242785 19221464 18984771 17049068 16873071 20005174 19288272 19189212 20859285 21138602 17261762 19189210 19410462 20065188 |
MESH:D001943 |
Breast Neoplasms |
|
temsirolimus |
14.11 | 16954435 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
14.11 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Vanadium |
14.11 | 15565634 |
MESH:D001986 |
Bronchial Spasm |
|
Histamine |
5.17 | 18298128 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.73 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
9.30 | 16374292 |
MESH:D002056 |
Burns |
|
Indomethacin |
9.30 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.36 | 11239499 15141370 15625704 16537180 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.82 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.16 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
7.02 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
7.02 | 19555203 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.88 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
22.53 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
22.53 | 11135700 14691202 15553829 16217749 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
deguelin |
22.53 | 18575727 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
22.53 | 16023760 18059187 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
22.53 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
22.53 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
22.53 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
22.53 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
22.53 | 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
22.53 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vanadium |
22.53 | 16830150 16878318 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
9.30 | 11053908 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.30 | 16675471 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.71 | 14736730 18791128 11352223 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.72 | 18414057 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.22 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
8.82 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
8.82 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
8.82 | 17341418 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.55 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
21.82 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
21.82 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
21.82 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Glutathione |
21.82 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
21.82 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
21.82 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
21.82 | 19435901 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
21.82 | 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.05 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
5.97 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
5.97 | 15728586 11179087 11754973 17287366 17124262 16170337 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.09 | 17308081 17974986 15476868 17924179 17131338 16952015 17329180 16242529 17351982 15811867 16269455 15792986 18627295 16109756 17519947 17382496 16364871 17928571 17007740 15505089 16612575 16731534 16455267 16651473 16278810 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.69 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.04 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.04 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
8.73 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
8.73 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Vanadium |
8.73 | 17174075 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
5.86 | 21254450 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
5.86 | 20678186 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.51 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.66 | 9022650 19486331 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.04 | 17157402 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.21 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
2.87 | 15513904 |
MESH:D003092 |
Colitis |
|
Curcumin |
7.73 | 18200517 16782535 16804969 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.73 | 16474422 |
MESH:D003103 |
Coloboma |
|
Curcumin |
3.97 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
11.89 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
11.89 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
11.89 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
11.89 | 15637740 15786552 15625704 15936596 11260862 15963497 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
11.89 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Vanadium |
11.89 | 18155637 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
5.53 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
5.53 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
5.53 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
5.53 | 12606626 11197048 18059344 17054584 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
5.53 | 16550006 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.27 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.31 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.57 | 12609071 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.06 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.72 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
4.72 | 15451039 15451040 11198716 19302082 10194807 15513904 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
4.72 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
4.72 | 12039119 9562676 |
MESH:D003550 |
Cystic Fibrosis |
|
Glutathione |
7.31 | 19747007 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
7.31 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.50 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.74 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.22 | 12868966 14531868 11906362 2524372 8156756 11298694 8970840 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.90 | 3621924 2952479 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.51 | 20191521 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.24 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
2.52 | 18403477 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
16.97 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
16.97 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
16.97 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
16.97 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
10.29 | 7237001 7907874 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
10.29 | 8112388 10446763 11488427 |
MESH:D003967 |
Diarrhea |
|
SU 5416 |
10.29 | 12673719 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
12.11 | 9022650 6679447 16192314 18692083 8291058 9328219 18648102 7440962 9653073 18289764 6482804 11289319 1440618 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
12.11 | 10092053 12628495 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
12.11 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.11 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
12.11 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
12.11 | 18071297 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.18 | 18602426 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.51 | 18446180 16133044 18043480 16326151 17190690 12774134 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
7.40 | 17351913 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
7.40 | 11535926 17351913 17151854 10671773 16699067 11595431 17329845 17202747 11595415 11991626 17045617 |
MESH:D004417 |
Dyspnea |
|
SU 5416 |
5.28 | 12649163 12673719 |
MESH:D004487 |
Edema |
|
Aspirin |
28.29 | 17259670 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
28.29 | 8273558 |
MESH:D004487 |
Edema |
|
imatinib |
28.29 | 19703484 |
MESH:D004487 |
Edema |
|
Indomethacin |
28.29 | 7907874 10653021 16100529 7990266 19703484 8273558 8985016 |
MESH:D004487 |
Edema |
|
resveratrol |
28.29 | 8985016 |
MESH:D004487 |
Edema |
|
Serotonin |
28.29 | 18841975 |
MESH:D004487 |
Edema |
|
Sodium Salicylate |
28.29 | 10653021 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
28.29 | 7812673 15177302 16716910 8273558 11698051 8113982 9599246 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
15-deoxy-delta(12,14)-prostaglandin J2 |
12.09 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
12.09 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
12.09 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
9.88 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
9.88 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
9.88 | 16202921 20544844 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
3.59 | 15652904 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.50 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
3.86 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.09 | 10567023 17763956 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
10.29 | 17980183 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
10.29 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Histamine |
11.75 | 12689652 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
11.75 | 11298111 |
MESH:D004802 |
Eosinophilia |
|
Pyrilamine |
11.75 | 1355641 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.52 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
11.52 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
11.52 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
11.52 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
11.52 | 11005569 |
MESH:D005221 |
Fatigue |
|
SU 5416 |
5.74 | 12649163 12673719 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
18.62 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
18.62 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
18.62 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
18.62 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.62 | 19224547 14986274 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.01 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.81 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.66 | 10194807 16946407 15513904 15451040 |
MESH:D005334 |
Fever |
|
Indomethacin |
3.56 | 11852909 10431976 17627676 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.36 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.89 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
15.91 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
15.91 | 17453242 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
15.91 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.25 | 10962813 |
MESH:D005355 |
Fibrosis |
|
arsenite |
11.46 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
11.46 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
11.46 | 17994277 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.20 | 7506515 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.51 | 11298111 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.65 | 16904648 |
MESH:D005756 |
Gastritis |
|
Ethanol |
9.35 | 15046732 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
9.35 | 15046732 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.07 | 18462866 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
17.59 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
17.59 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
17.59 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
17.59 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
17.59 | 17162496 |
MESH:D005910 |
Glioma |
|
Indomethacin |
2.93 | 16487511 18371953 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.76 | 11849393 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.44 | 7505956 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.71 | 11248219 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
4.52 | 16518429 |
MESH:D006261 |
Headache |
|
Aspirin |
9.45 | 15240983 |
MESH:D006261 |
Headache |
|
SU 5416 |
9.45 | 12649163 12673719 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
14.80 | 18462866 18829502 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
14.80 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
14.80 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
14.80 | 19435901 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.02 | 17875725 18006777 16144979 16879835 16330681 17888722 18674790 16707910 16244371 12587719 16244372 16495754 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.40 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Propranolol |
6.40 | 20082655 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.33 | 15692506 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
3.99 | 15633222 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
2.91 | 6705139 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.07 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
Propranolol |
4.47 | 16371745 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.41 | 17701891 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.38 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.55 | 16876885 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.00 | 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
2.88 | 15147373 18501091 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.10 | 17088409 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.11 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
10.45 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
10.45 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
10.45 | 12727271 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.06 | 17883296 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.65 | 17019078 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
7.47 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
7.47 | 17188708 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.36 | 12524144 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
7.53 | 17546600 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
7.53 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.31 | 15034207 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
2.80 | 12717712 8949925 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
9.09 | 18502941 12791704 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
9.09 | 19211884 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.74 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.11 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.55 | 17426086 |
MESH:D007022 |
Hypotension |
|
Propranolol |
4.59 | 6740701 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.37 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.71 | 10651667 10647630 16133968 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.20 | 7506515 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.72 | 16133044 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.02 | 17600658 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
18.51 | 8273558 |
MESH:D007249 |
Inflammation |
|
Curcumin |
18.51 | 16956363 17151092 18403477 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
18.51 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
18.51 | 7812673 3291741 12568917 |
MESH:D007249 |
Inflammation |
|
resveratrol |
18.51 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
18.51 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
18.51 | 8273558 7562506 7812673 11698051 15177302 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.91 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
3.89 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.53 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
3.70 | 15610444 15831440 11855677 11713966 10210152 11686837 17994277 17329856 18236018 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.66 | 10783313 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.72 | 15241188 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.36 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
3.83 | 15513904 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.37 | 16133968 18306037 10574470 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.00 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
7.87 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
7.87 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
7.87 | 17190690 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.21 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.21 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.35 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
9.35 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
9.35 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.39 | 16316344 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.51 | 9562676 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.59 | 15451040 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
3.98 | 18555241 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.38 | 11703811 12228301 10320625 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
8.56 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
8.56 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
8.56 | 18462866 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.50 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
7.85 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
7.85 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
15.97 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
15.97 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
15.97 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
11.40 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
11.40 | 19208803 17301526 15107311 15748426 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
11.40 | 16572323 15631656 10785260 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.07 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
8.07 | 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
7.59 | 17077328 16467208 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
7.59 | 16467208 17050201 19850784 20471514 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
7.59 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
SU 5416 |
7.59 | 12649163 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
10.47 | 17077328 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
10.47 | 11161223 16331271 12679006 16112521 16823087 15748426 16966277 17712046 17649720 12018890 17217047 15336539 17869043 12712474 15622746 19642359 19225113 17107899 16330433 9834237 15213294 19035177 16891316 19075265 11468182 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
10.47 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
9.68 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
9.68 | 16106398 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.72 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.06 | 17980183 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.34 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.68 | 15342952 17567588 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.06 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
9.01 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
9.01 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
9.01 | 14986274 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.45 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.77 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
13.34 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
13.34 | 18637143 17666798 16603200 16009107 15793283 17036385 18239293 15067225 14659978 15081153 15504291 15366600 16627068 17640959 17203207 17724770 18629640 17201889 15744066 18237412 15138612 15479170 17534399 15339415 15577212 16042886 17881167 17432682 18567088 15763062 15591649 15383259 15723089 16270385 18210741 18364076 15161499 15864749 15798949 14643895 16169303 14709902 16570917 14726149 17348192 15942678 17198567 15571005 17465448 17196135 14568256 18672772 18371158 15298665 15369754 17719030 18095165 15733078 12918455 12925901 16544323 15842777 15099470 15086199 15492853 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
13.34 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
13.34 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
13.34 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
13.34 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
13.34 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
13.34 | 17050028 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
13.34 | 18564211 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
2.44 | 16956363 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.03 | 17347304 17207112 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
3.85 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
8.36 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
8.36 | 3113478 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
8.36 | 20405173 19812893 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
8.36 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.15 | 1399818 598648 6587162 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.15 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
14.15 | 15603536 6150874 1848544 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.15 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vanadium |
14.15 | 17174075 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.85 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.37 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
15.33 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
15.33 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
15.33 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
15.33 | 18462866 19359593 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
deguelin |
15.33 | 19336726 16288123 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
15.33 | 19555203 16061637 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
15.33 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
15.33 | 16537180 11497255 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
15.33 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
15.33 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
9.96 | 18462866 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
9.96 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
9.96 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.71 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.11 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.11 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
9.48 | 16173963 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
9.48 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.88 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.88 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
14.19 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
14.19 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
14.19 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
14.19 | 16827153 19196723 11731420 19196722 14580682 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
14.19 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.48 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.48 | 19453300 |
MESH:D008545 |
Melanoma |
|
Curcumin |
12.93 | 18462866 17885582 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
12.93 | 16827129 |
MESH:D008545 |
Melanoma |
|
Histamine |
12.93 | 17709802 |
MESH:D008545 |
Melanoma |
|
resveratrol |
12.93 | 17992120 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
12.93 | 19282848 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
12.93 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
temsirolimus |
12.93 | 17508024 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.54 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
7.73 | 17263510 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
7.73 | 18411066 15451040 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.76 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.80 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
6.46 | 15240983 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
6.46 | 11903285 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.92 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
7.54 | 12636206 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
7.54 | 19435901 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
10.39 | 17415656 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
10.39 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
9.44 | 15949261 11468182 19417148 14977855 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
9.44 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
9.44 | 16490592 17049120 17935668 14749477 17164350 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
10.28 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
10.28 | 17962980 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.02 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.80 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
SU 5416 |
6.80 | 12649163 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
7.86 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
7.86 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
7.86 | 16317513 16456233 17015251 17125593 17188708 16525036 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
3.49 | 17125593 17015251 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.78 | 16810080 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.12 | 17322642 |
MESH:D009325 |
Nausea |
|
Aspirin |
4.56 | 15240983 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
8.30 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.30 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
14.71 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
14.71 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
14.71 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
14.71 | 11239499 11053908 16537180 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
14.71 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.27 | 19410462 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
6.82 | 16946489 |
MESH:D009369 |
Neoplasms |
|
deguelin |
6.82 | 17764071 |
MESH:D009369 |
Neoplasms |
|
SU 5416 |
6.82 | 17264769 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
7.34 | 15625704 10663608 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.34 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
14.64 | 12497104 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
14.64 | 17614352 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
14.64 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
8.03 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.03 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.14 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.45 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.05 | 16427766 11399458 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
4.98 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
5.77 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
5.77 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
2.90 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
6.98 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
6.98 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.81 | 17929310 |
MESH:D009765 |
Obesity |
|
Curcumin |
2.56 | 19297423 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.51 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
2.86 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.36 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
6.62 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
6.62 | 7009135 |
MESH:D010014 |
Osteolysis |
|
imatinib |
5.10 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
6.14 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
6.14 | 18719352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.66 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.59 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
12.30 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
12.30 | 19769630 12452020 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
12.30 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
12.30 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
12.30 | 16211241 |
MESH:D010146 |
Pain |
|
Aspirin |
5.61 | 6995502 6363464 |
MESH:D010146 |
Pain |
|
Indomethacin |
5.61 | 3291741 17440234 13679232 17627676 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.03 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
10.08 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
10.08 | 19196508 17440100 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
10.08 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
10.08 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.34 | 15028970 17883296 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
12.03 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
12.03 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
12.03 | 18404319 12065085 18922899 8330346 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.57 | 19927285 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.06 | 16537180 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
3.47 | 19682553 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.56 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.06 | 11903285 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.51 | 11148446 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
4.90 | 11156591 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.26 | 17225004 |
MESH:D020795 |
Photophobia |
|
Aspirin |
5.11 | 15240983 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.82 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.50 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.50 | 17638057 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.35 | 16144296 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
4.09 | 12476293 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.50 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
3.55 | 16679765 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.94 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
8.94 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Apigenin |
1.98 | 17132221 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.98 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
1.98 | 18769126 11398177 12497104 18226269 18156803 10851300 15129424 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.98 | 15749863 15897917 16868541 18437689 16888761 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.98 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.98 | 17636462 17718901 17675339 15767336 16731767 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.98 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
3.57 | 11849393 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.17 | 17410198 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
3.96 | 19168576 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
8.42 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
8.42 | 17352296 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.93 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
2.92 | 17520802 16317513 16314181 17058453 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
3.44 | 10666014 18379247 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.88 | 3692021 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
7.59 | 12372130 |
MESH:D012220 |
Rhinitis |
|
Histamine |
7.59 | 12689652 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
7.70 | 18462866 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
7.70 | 18313854 17710206 16767912 17203757 15675481 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
13.85 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
13.85 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
13.85 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.15 | 17846226 |
MESH:D012640 |
Seizures |
|
Ethanol |
2.74 | 9754883 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.54 | 18389075 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.55 | 16631401 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.06 | 7327846 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
4.64 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
deguelin |
14.30 | 16041863 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
14.30 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
14.30 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
14.30 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
14.30 | 8985016 11807781 18404319 8330346 12065085 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.94 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.64 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.40 | 19457130 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.62 | 12587719 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
3.78 | 18209964 17160473 10192188 17207306 16113693 16184426 17638125 10486359 18545984 10215738 15038085 16280098 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
5.44 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
5.44 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
5.44 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
5.44 | 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
5.44 | 15609394 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
8.91 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
8.91 | 9211565 9562338 16755016 11906479 17189318 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
8.91 | 11595415 10878458 11145282 10750652 18181030 16169175 14567935 16150113 18209962 17918041 12467913 17977527 11595431 16631530 16934674 17895592 11729361 10423059 12498302 17135157 12500499 18543354 16252198 17657623 16397915 17627676 15104355 11906479 18299717 18193104 12077510 12787963 18237397 18431645 18087811 1323529 15138204 17654042 11523592 16755016 15255614 18726076 |
MESH:D020521 |
Stroke |
|
Aspirin |
3.86 | 16403987 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.91 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.69 | 9754883 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.42 | 9562676 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
8.29 | 17672075 |
MESH:D013927 |
Thrombosis |
|
SU 5416 |
8.29 | 12649163 |
MESH:D013964 |
Thyroid Neoplasms |
|
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
21.59 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
21.59 | 3712494 6582329 6587162 1399818 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
21.59 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
21.59 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
21.59 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
21.59 | 14736730 18791128 11352223 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.03 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.65 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.32 | 15213294 |
MESH:D014402 |
Tuberous Sclerosis |
|
everolimus |
10.78 | 18495876 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
10.78 | 18495876 21115397 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.25 | 17380554 10574470 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.60 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
12.60 | 11780464 20435036 12845720 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
12.60 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
12.60 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.60 | 16712894 17572228 8653321 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.62 | 18462866 |
MESH:D014581 |
Urticaria |
|
Aspirin |
7.70 | 20485159 10982225 |
MESH:D014581 |
Urticaria |
|
Histamine |
7.70 | 18298128 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
3.54 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.53 | 17044934 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
4.98 | 1336536 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.27 | 17638931 17678736 16364871 17334414 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.27 | 17488730 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.09 | 11897121 |
MESH:D014947 |
Wounds and Injuries |
|
lysophosphatidic acid |
4.78 | 15541073 |